icone plus 
	     
	    
	    
	    	
	
	
		
		
	
	     
	    
		
			
		 
		
			
		 
		
			
			
			
		 
		
			
				Contact Abonnez-vous aux actualités 
			 
		 
		
	 
 
     
    
   
  
  
	 
	 
	 
	 
	 
 
  
	 
	
		
			
			
			
				
  
    
  
	
    
        
            
            
                
                
	                
	                 
	                    
	                    
	                        
	                            
								
									Reason for request 
									
										Inclusion
									
									
								 	
												
									                            
								
									
										
										
											
 
 
  
 
										
									
									
								
						 		
						 		
						 			
										Clinical Benefit 
									 
									
										
											
											
												Substantial 
												
													
														
															Substantial actual benefit
 
												
											 
										
									
									
								
								
								
						 			Clinical Added Value 
										
											
											
												no clinical added value 
												
													
														
															EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
 
												
											 
										
									
									
								
						 
						 		
						 		
								
						 		
								
	                         
	                     
                 
				
				
    
             
         
     
	
 
        
  
			
		
	 
	
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
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
GefuSHhN6PQdw0KN